Janita Ardis
Psychiatry · Oklahoma City, OKNPI 1245382993
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 383 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$953
- Sunovion Pharmaceuticals Inc.$873
- Otsuka America Pharmaceutical, Inc.$603
- Teva Pharmaceuticals USA, Inc.$594
- Takeda Pharmaceuticals U.S.A., Inc.$495
- Vanda Pharmaceuticals Inc.$402
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,76099%
- Education$711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 99 | $953 |
| Sunovion Pharmaceuticals Inc. | 49 | $873 |
| Otsuka America Pharmaceutical, Inc. | 32 | $603 |
| Teva Pharmaceuticals USA, Inc. | 42 | $594 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $495 |
| Vanda Pharmaceuticals Inc. | 17 | $402 |
| Johnson & Johnson | 26 | $342 |
| Lundbeck LLC | 12 | $236 |
| Merck | 12 | $222 |
| Bausch Health US, LLC | 10 | $203 |
| Neurocrine Biosciences, Inc. | 9 | $140 |
| Supernus Pharmaceuticals, Inc. | 8 | $134 |
| Jazz Pharmaceuticals Inc. | 7 | $128 |
| Ironshore Pharmaceuticals Inc. | 5 | $92 |
| Eisai Inc. | 5 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $69 |
| Adlon Therapeutics L.p. | 5 | $67 |
| Neos Therapeutics, LP | 4 | $64 |
| Avanir Pharmaceuticals, Inc. | 3 | $53 |
| Acadia Pharmaceuticals Inc | 2 | $38 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Indivior Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$106
How this compares
$5,832 in reported general payments places this provider in the 90th percentile of 328 psychiatry providers in Oklahoma.
Other psychiatry in Oklahoma City
- Willis HollowayOklahoma City$92K
- Adonis Al BotrosOklahoma City$73K
- Marvin PeytonOklahoma City$60K
- Josephine DeguzmanOklahoma City$38K
- Haisam Al KhouriOklahoma City$10K
- Patrick HornOklahoma City$8K
- Shreekuma VinekarOklahoma City$7K
- Relindis TitaOklahoma City$6K
- Fiona LiOklahoma City$5K
- Ahsan KhanOklahoma City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.